Navigation Links
Modified antibiotic may support fight cancer

According to recent experiments a molecule related to tetracycline can aid stop the spread of cancer cells. Researchers at the University of Iowa have been looking at a new drug called COL-3,// which is related to the well-known antibiotic tetracycline. In a series of experiments, they find that COL-3 acts upon the tissue surrounding a tumour, making that tumour less likely to spread throughout the body.

COL-3 appears to block some of the chemical signals that come from an existing tumour that otherwise encourage cancer cells' movement throughout the surrounding tissue. It may be that COL-3 would be useful in conjunction with conventional anti-cancer drugs which kill cancer cells. Further research will reveal whether this new approach is applicable to the long-term management of human cancer.


'"/>




Page: 1

Related medicine news :

1. Malaria To Be Tackled By Genetically Modified Mosquitoes
2. Stroke Rehabilitation Through Modified Video Games
3. Genetically Modified Cells Attack Tumors
4. TB can Be Eradicated in the U.S With Modified Guidelines: Study
5. Modified Ligament Surgery Improves Outcomes Players, Athletes
6. New antibiotic already developing resistance
7. Gene clue to antibiotics
8. Excessive use of antibiotics for sore throat
9. E. coli strains resistant to a common antibiotic
10. Cost-effective antibiotics for sinusitis treatment
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest ... . , Millions of individuals in the United States and Canada wear eyeglasses. Once ... to both correct vision and make a fashion statement. Even celebrities use glasses as ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: